These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4836147)

  • 21. [Diagnosis of susceptibility to malignant hyperthermia in children].
    Krivosic-Horber R; Adnet P; Krivosic I; Reyford H
    Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
    Brandom BW; Muldoon SM
    Paediatr Anaesth; 2013 Sep; 23(9):851-4. PubMed ID: 23848295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant hyperthermia.
    Gatz EE; Wingard DW
    Nebr Med J; 1973 Dec; 58(12):434-7. PubMed ID: 4589059
    [No Abstract]   [Full Text] [Related]  

  • 24. Malignant hyperthermia: a possible new variant.
    Lee DS; Adams JP; Zimmerman JE
    Can Anaesth Soc J; 1985 May; 32(3 Pt 1):268-71. PubMed ID: 4005678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central core disease and malignant hyperthermia syndrome.
    Frank JP; Harati Y; Butler IJ; Nelson TE; Scott CI
    Ann Neurol; 1980 Jan; 7(1):11-7. PubMed ID: 7362206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Case of malignant hyperthermia].
    Pogorel'tsev AG; Kochnev AN; Dorofeev AI; Tishin PE; Favr VV
    Vestn Khir Im I I Grek; 1976 Nov; 117(11):111. PubMed ID: 1014244
    [No Abstract]   [Full Text] [Related]  

  • 27. A fatal case of malignant hyperthermia during anaesthesia and a study of the patient's blood relatives.
    Kaukinen S; Stenberg J; Kaukinen L
    Ann Chir Gynaecol Fenn; 1974; 63(3):212-6. PubMed ID: 4411635
    [No Abstract]   [Full Text] [Related]  

  • 28. Malignant hyperthermia susceptibility in patients with Duchenne's muscular dystrophy.
    Peluso A; Bianchini A
    Can J Anaesth; 1992 Dec; 39(10):1117-8. PubMed ID: 1464140
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: Malignant hyperthermia in the dog.
    Short CE; Paddleford RR
    Anesthesiology; 1973 Oct; 39(4):462-3. PubMed ID: 4758363
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biochemical and electromyographic studies on a family with malignant hyperpyrexia].
    Konno K; Yamashiro H; Hagiwara M; Haseba J; Honda N
    Masui; 1974 Sep; 23(9):854-61. PubMed ID: 4475138
    [No Abstract]   [Full Text] [Related]  

  • 31. [Application of caffeine-halothane contracture test in the diagnosis of malignant hyperthermia].
    Wang YL; Guo XY; Xu ZH; Huang YG; Luo AL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Apr; 30(2):182-6. PubMed ID: 18505122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.
    O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE
    Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant hyperthermia susceptibility revealed by increased serum creatine kinase concentrations during statin treatment.
    Krivosic-Horber R; Dépret T; Wagner JM; Maurage CA
    Eur J Anaesthesiol; 2004 Jul; 21(7):572-4. PubMed ID: 15318472
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
    Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
    Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant hyperthermia. An historical vignette.
    Harrison GG; Isaacs H
    Anaesthesia; 1992 Jan; 47(1):54-6. PubMed ID: 1536407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoenzymes of creatine phosphokinase in serum of families with malignant hyperpyrexia.
    Meltzer HY; Hassan SZ; Russo P; Cho HW
    Anesth Analg; 1976; 55(6):797-9. PubMed ID: 1033694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A family with intussusception and malignant hyperthermia.
    Jolly DT; McKim JC; Corrin MH
    Can Med Assoc J; 1982 Oct; 127(8):737-8. PubMed ID: 7139491
    [No Abstract]   [Full Text] [Related]  

  • 38. Be alert for symptoms of malignant hyperthermia.
    Edwards DB
    Dent Stud; 1977 Jun; 55(9):33-4, 39. PubMed ID: 271097
    [No Abstract]   [Full Text] [Related]  

  • 39. The King syndrome: malignant hyperthermia, myopathy, and multiple anomalies.
    McPherson EW; Taylor CA
    Am J Med Genet; 1981; 8(2):159-65. PubMed ID: 7282770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unexplained increases in serum creatine kinase levels: its relation to malignant hyperthermia susceptibility.
    Lingaraju N; Rosenberg H
    Anesth Analg; 1991 May; 72(5):702-5. PubMed ID: 2018229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.